Published in Cancer Weekly, July 31st, 1995
Newly reported studies also concluded that piperacillin/tazobactam is as effective as commonly used combination regimens or imipenem for the treatment of intra-abdominal infections and that the antibiotic is more effective than currently used regimens when combined with tobramycin, for hospital-acquired lower respiratory tract infections.
These studies were reported at the 19th International Congress of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.